Dow Chemical Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-21,080
Closed -$628K 65
2015
Q3
$628K Hold
21,080
0.05% 83
2015
Q2
$671K Hold
21,080
0.06% 91
2015
Q1
$696K Hold
21,080
0.06% 84
2014
Q4
$623K Hold
21,080
0.06% 81
2014
Q3
$591K Hold
21,080
0.05% 85
2014
Q2
$594K Hold
21,080
0.05% 83
2014
Q1
$642K Hold
21,080
0.05% 79
2013
Q4
$613K Hold
21,080
0.05% 68
2013
Q3
$574K Buy
+21,080
New +$574K 0.05% 64

Other funds holding PFE

Dow Chemical Company's PFE Position: Q4 2015 in Review

Dow Chemical Company sold out of Pfizer (PFE) in Q4 2015, closing a stake of 21,080 shares — an estimated $628K sold.

Dow Chemical Company first reported a position in PFE in Q3 2013 and held it in 9 quarters. The position peaked at $696K in Q1 2015. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Dow Chemical Company reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
  • Dow Chemical Company sold 21,080 Pfizer shares in Q4 2015, an estimated $628K.
  • Dow Chemical Company first reported a position in Pfizer in Q3 2013 and held it in 9 quarters.
  • Dow Chemical Company's Pfizer position peaked at $696K in Q1 2015.
  • 1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Dow Chemical Company's 13F filing for Q4 2015, filed 16 Feb 2016.